Catalent said today that it plans to purchase Cook Pharmica for $950 million in cash.
Cook Pharmica, a unit of privately-held medical device maker Cook Group, is a contract manufacturer that develops biologics-based drug compounds.
Get the full story at our sister site, Drug Delivery Business News.
The post Catalent dishes out $950m for biologics manufacturer appeared first on MassDevice.